MAY 21, 2017 5:09 PM PDT

The World's First Mitral Valve Repair Through the Jugular Vein

WRITTEN BY: Kara Marker

Canadian cardiologist Dr. Neil Fam completed the world’s first mitral regurgitation repair surgery through the jugular vein, giving an 86-year-old woman with heart failure and few other options a new lease on life.

Dr. Neil Fam is an interventional cardiologist and director of the Cardiac Intensive Care Unit of St. Michael's Hospital in Toronto. Credit: St. Michael's Hospital

Using a Canadian-invented device, Fam conducted the catheter-based treatment through the jugular vein instead of the more traditional route, through the femoral vein. His patient had severe mitral regurgitation, a heart condition where blood leaks backward through the mitral valve upon contraction of the left ventricle. At the very least, mitral regurgitation can lead to high blood pressure. In the most severe cases, it can cause congestion in the lungs.

The woman also had severe heart failure that wasn’t responding to drugs. Along with her age, she was ultimately not a good candidate for invasive mitral valve surgery. However, the alternative - the traditional catheter-based approach through the femoral vein - wouldn’t work either, because the vein was blocked. Fam described the situation as being “locked out, blocked from accessing her heart.” The only option left, Fam decided, was to conduct a risky procedure where a catheter is guided through a tricky angle in the jugular vein.

Baylis Medical Company, Inc’s SupraCross RF Solution was what Fam turned to when he and the patient decided to go ahead with the procedure. Fam used a catheter to send a MitraClip through the jugular vein, all the way to the heart to repair the leaking mitral valve. The MitraClip technology is steerable and delivers radiofrequency to puncture the heart’s septum, which is required for the catheter to reach the mitral valve to make the repair.

As the patient recovered from the surgery, Fam saw no complications and no further heart failure.

"Given the success of this procedure, the door is open for future studies of the jugular approach for treating the mitral valve," he said. However, the procedure will only be for specific, high-risk patients with no other options.

Fam published a report of the successful procedure in the journal Eurointervention.

Sources: MitraClip, Mayo Clinic, American Heart Association, St. Michael’s Hospital

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 26, 2021
Coronavirus
LIBRA-Seq ID's a Potent Antibody to Fight COVID-19
SEP 26, 2021
LIBRA-Seq ID's a Potent Antibody to Fight COVID-19
Humans can produce millions or even billions of antibodies, so only so many can be captured and screened. But those anti ...
SEP 30, 2021
Drug Discovery & Development
Exosome delivery of an anti-HIV drug to the brain
SEP 30, 2021
Exosome delivery of an anti-HIV drug to the brain
The body has a remarkable ability to prevent foreign objects, such as toxins or other pathogens, from entering the brain ...
OCT 03, 2021
Microbiology
Using a New Approach to Assess Aging & the Microbiome
OCT 03, 2021
Using a New Approach to Assess Aging & the Microbiome
Metagenomic tools enable scientists to easily sequence all of the DNA in any sample, like soil, or feces. The results ca ...
OCT 12, 2021
Immunology
Major Landmark in a 100-Year Search for a Malaria Vaccine
OCT 12, 2021
Major Landmark in a 100-Year Search for a Malaria Vaccine
In one of the greatest global health milestones of our time, the World Health Organization has approved the widespread d ...
OCT 13, 2021
Earth & The Environment
Fighting Back Against Harmful Algal Blooms
OCT 13, 2021
Fighting Back Against Harmful Algal Blooms
Harmful algal blooms, or HABs, are a common summertime nuisance for people that live near fresh or saltwater all over th ...
OCT 14, 2021
Drug Discovery & Development
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
OCT 14, 2021
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
The conjunctiva is a thin membrane that covers the front of the eyes and the inner eyelids. The conjunctiva produces tea ...
Loading Comments...